MetaCap

Acumen Pharmaceuticals Inc. Company Profile

NASDAQ: ABOSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.1865-0.0068 (-3.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Acumen Pharmaceuticals at a glance

Acumen Pharmaceuticals Inc. (NASDAQ: ABOS) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Newton, MA. Acumen Pharmaceuticals is led by Mr. Daniel J. O'Connell M.B.A. and employs about 60 people. The company's shares have traded publicly since 2021.

At a market capitalization of $13.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001576885, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Acumen Pharmaceuticals do?

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. It focuses on advancing a targeted immunotherapy drug candidate, sabirnetug (ACU193), which is in its Phase 2 ALTITUDE-AD clinical trial to target toxic soluble amyloid beta oligomers. Acumen Pharmaceuticals, Inc. has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug, as well as with JCR Pharmaceuticals Co. Ltd for the development of Aß oligomer-targeted enhanced brain delivery therapy for the treatment of Alzheimer's disease. The company was incorporated in 1996 and is headquartered in Newton, Massachusetts.

Business description based on the company's public filings.

Company information

Legal name
Acumen Pharmaceuticals Inc.
Ticker
NASDAQ: ABOS
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
CEO
Mr. Daniel J. O'Connell M.B.A.
Employees
60
Headquarters
1210-1220 Washington St., Newton, MA, United States
Phone
617 344 4190
IPO year
2021
Market cap
$13.49M
SEC CIK
0001576885
Latest annual report
10-K · Mar 26, 2026

Companies similar to Acumen Pharmaceuticals

ABOS peer companies
CompanyPrice% ChgMarket capCompare
PLURPluri Inc.0.94-3.07%$13.51Mvs ABOS
ESLAEstrella Immunopharma Inc.0.321-5.70%$14.11Mvs ABOS
PASGPassage Bio Inc.3.92+11.68%$12.61Mvs ABOS
BSEMBioStem Technologies Inc.0.6351-10.23%$12.18Mvs ABOS
BCDABioCardia Inc.0.785+1.60%$11.88Mvs ABOS
DYAIDyadic International Inc.0.287-7.66%$11.51Mvs ABOS
TCRXTScan Therapeutics Inc.0.1459+2.24%$9.89Mvs ABOS
ATYRaTyr Pharma Inc.3.82+3.52%$9.74Mvs ABOS

Related